JP2017504576A5 - - Google Patents

Download PDF

Info

Publication number
JP2017504576A5
JP2017504576A5 JP2016536162A JP2016536162A JP2017504576A5 JP 2017504576 A5 JP2017504576 A5 JP 2017504576A5 JP 2016536162 A JP2016536162 A JP 2016536162A JP 2016536162 A JP2016536162 A JP 2016536162A JP 2017504576 A5 JP2017504576 A5 JP 2017504576A5
Authority
JP
Japan
Prior art keywords
phenyl
acetamide
hydroxypropan
hexafluoro
cyclopropylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016536162A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017504576A (ja
JP6461960B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/076390 external-priority patent/WO2015082533A1/en
Publication of JP2017504576A publication Critical patent/JP2017504576A/ja
Publication of JP2017504576A5 publication Critical patent/JP2017504576A5/ja
Application granted granted Critical
Publication of JP6461960B2 publication Critical patent/JP6461960B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016536162A 2013-12-05 2014-12-03 RORガンマ(γ)モジュレータ Expired - Fee Related JP6461960B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP13195813 2013-12-05
EP13195813.4 2013-12-05
EP14183274 2014-09-02
EP14183274.1 2014-09-02
PCT/EP2014/076390 WO2015082533A1 (en) 2013-12-05 2014-12-03 Ror gamma (rory) modulators

Publications (3)

Publication Number Publication Date
JP2017504576A JP2017504576A (ja) 2017-02-09
JP2017504576A5 true JP2017504576A5 (enExample) 2018-12-27
JP6461960B2 JP6461960B2 (ja) 2019-01-30

Family

ID=52021176

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016536162A Expired - Fee Related JP6461960B2 (ja) 2013-12-05 2014-12-03 RORガンマ(γ)モジュレータ

Country Status (29)

Country Link
US (1) US9738600B2 (enExample)
EP (1) EP3077372B8 (enExample)
JP (1) JP6461960B2 (enExample)
KR (1) KR102251128B1 (enExample)
CN (1) CN105980353B (enExample)
AU (1) AU2014359324B2 (enExample)
CA (1) CA2932483C (enExample)
CL (1) CL2016001364A1 (enExample)
CR (1) CR20160303A (enExample)
DK (1) DK3077372T3 (enExample)
DO (1) DOP2016000125A (enExample)
EA (1) EA030393B1 (enExample)
ES (1) ES2722409T3 (enExample)
HR (1) HRP20190483T1 (enExample)
HU (1) HUE043258T2 (enExample)
IL (1) IL246018B (enExample)
LT (1) LT3077372T (enExample)
MX (1) MX368721B (enExample)
MY (1) MY179106A (enExample)
PE (1) PE20160891A1 (enExample)
PH (1) PH12016501066A1 (enExample)
PL (1) PL3077372T3 (enExample)
PT (1) PT3077372T (enExample)
RS (1) RS58650B1 (enExample)
SI (1) SI3077372T1 (enExample)
TN (1) TN2016000224A1 (enExample)
UA (1) UA117941C2 (enExample)
WO (1) WO2015082533A1 (enExample)
ZA (1) ZA201604043B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2942871A1 (en) * 2014-03-27 2015-10-01 Piramal Enterprises Limited Ror-gamma modulators and uses thereof
CA2940264A1 (en) * 2014-04-16 2015-10-22 Glenmark Pharmaceuticals S.A. Aryl and heteroaryl ether compounds as ror gamma modulators
TWI705057B (zh) 2014-10-30 2020-09-21 比利時商健生藥品公司 用作RORγt調節劑之三氟甲基醇
US9861618B2 (en) 2014-10-30 2018-01-09 Janssen Pharmaceutica Nv Thiazoles as modulators of RORγt
WO2016069978A1 (en) 2014-10-30 2016-05-06 Janssen Pharmaceutica Nv AMIDE SUBSTITUTED THIAZOLES AS MODULATORS OF RORγT
CN107614062A (zh) 2015-03-12 2018-01-19 加利福尼亚大学董事会 用RORγ抑制剂治疗癌症的方法
KR102702236B1 (ko) 2015-05-15 2024-09-04 오리진 온콜로지 리미티드 Ror 감마 조절제로서의 치환된 테트라하이드로퀴놀리논 화합물
WO2016193894A1 (en) * 2015-05-29 2016-12-08 Glenmark Pharmaceuticals S.A. Treatment of respiratory disorders using ror- gamma inhibitors
EP3101008A1 (en) * 2015-06-05 2016-12-07 Lead Pharma Cel Models IP B.V. Ror gamma (rory) modulators
EP3101005A1 (en) * 2015-06-05 2016-12-07 Lead Pharma Cel Models IP B.V. Ror gamma (rory) modulators
WO2017010399A1 (ja) * 2015-07-10 2017-01-19 塩野義製薬株式会社 RORγt阻害作用を有する化合物およびそれらを含有する医薬組成物
KR101947976B1 (ko) 2015-12-15 2019-02-13 아스트라제네카 아베 이소인돌 화합물
TW201803869A (zh) 2016-04-27 2018-02-01 健生藥品公司 作為RORγT調節劑之6-胺基吡啶-3-基噻唑
WO2018011747A1 (en) * 2016-07-14 2018-01-18 Cadila Healthcare Limited Polycyclic compounds as ror-gamma modulators
TW201811760A (zh) 2016-07-14 2018-04-01 印度商卡迪拉保健有限公司 新穎的環丙基衍生物
AR110481A1 (es) 2016-12-05 2019-04-03 Lead Pharma Holding Bv MODULADORES DE ROR g (RORg)
WO2018116285A1 (en) * 2016-12-23 2018-06-28 Glenmark Pharmaceuticals S.A. Substituted morpholine derivatives as ror gamma modulators
EP3638661A1 (en) 2017-06-14 2020-04-22 Astrazeneca AB 2,3-dihydroisoindole-1-carboxamides useful as ror-gamma modulators
CN112566901A (zh) 2018-06-18 2021-03-26 詹森药业有限公司 作为RORγt的调节剂的苯基取代的吡唑类
US10975057B2 (en) 2018-06-18 2021-04-13 Janssen Pharmaceutica Nv 6-aminopyridin-3-yl pyrazoles as modulators of RORgT
US11034658B2 (en) 2018-06-18 2021-06-15 Janssen Pharmaceutica Nv Pyridinyl pyrazoles as modulators of RORγT
CN112334450A (zh) 2018-06-18 2021-02-05 詹森药业有限公司 作为RORγt的调节剂的苯基和吡啶基取代的咪唑
CN113874080B (zh) 2019-02-06 2024-09-27 戴斯阿尔法公司 Il-17a调节剂及其用途
JP7566889B2 (ja) * 2019-09-16 2024-10-15 ダイス・アルファ・インコーポレイテッド Il-17aモジュレーターおよびその使用
CN112759541B (zh) * 2019-10-21 2023-03-17 复旦大学 类吲哚衍生物及其用途
TW202136238A (zh) * 2020-01-06 2021-10-01 大陸商廣東東陽光藥業有限公司 RORγt抑制劑及其製備方法和用途
CN113072521B (zh) * 2020-01-06 2024-04-05 广东东阳光药业股份有限公司 RORγt抑制剂及其在药物中的应用
CN114075139B (zh) * 2020-08-14 2025-09-26 广东东阳光药业股份有限公司 五元杂芳环类化合物及其在药物中的应用
CN120383557A (zh) * 2024-01-26 2025-07-29 上海医药集团股份有限公司 一种乙磺酰苯基乙酰胺类化合物的晶型、其制备方法及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011115892A1 (en) * 2010-03-15 2011-09-22 Griffin Patrick R Modulators of the retinoic acid receptor-related orphan receptors
WO2012027965A1 (en) * 2010-09-01 2012-03-08 Glaxo Group Limited Novel compounds
WO2013029338A1 (en) * 2011-09-01 2013-03-07 Glaxo Group Limited Novel compounds
WO2014062655A1 (en) * 2012-10-16 2014-04-24 Janssen Pharmaceutica Nv HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt
WO2013171729A2 (en) 2013-01-08 2013-11-21 Glenmark Pharmaceuticals S.A. Aryl and heteroaryl amide compounds as rorgamat modulator
CN105121404A (zh) * 2013-03-15 2015-12-02 豪夫迈·罗氏有限公司 作为RORc调节剂的芳基磺酰胺和氨基磺酸衍生物
EP2781217A1 (en) * 2013-03-18 2014-09-24 ETH Zurich ROR gamma modulators

Similar Documents

Publication Publication Date Title
RU2351590C2 (ru) Способ получения диариламина
TWI685491B (zh) 製備5-(4-環丙基-1h-咪唑-1-基)-n-(6-(4-異丙基-4h-1,2,4-三唑-3-基)吡啶-2-基)-2-氟-4-甲基苯甲醯胺之方法
AU2014359324B2 (en) ROR gamma (RORy) modulators
JP6511346B2 (ja) ハロゲン化環式化合物の合成方法
RU2270194C2 (ru) Бензофеноны как ингибиторы il-1бета и tnf-альфа, фармацевтическая композиция и способ лечения
JP2016121196A5 (enExample)
JP2016505058A5 (enExample)
JP2008510770A5 (enExample)
JP2021513982A (ja) P300/cbp hat阻害剤及びそれらの使用の方法
JP2006517235A5 (enExample)
JP2016519165A5 (enExample)
JP2013521301A5 (enExample)
JP2013537535A (ja) Statタンパク質の阻害剤としての、置換2−ヒドロキシ−4−(2−(フェニルスルホンアミド)アセトアミド)安息香酸類似体
JP2019527724A5 (enExample)
JP2017534653A (ja) ブロモドメイン及びエキストラ末端タンパク質の阻害のための方法及び組成物
JP2020532550A (ja) リゾホスファチジン酸受容体1(lpar1)阻害剤化合物
RU2014145481A (ru) Циклопропанкарбоксилатные эфиры пуриновых аналогов
JP2016540803A5 (enExample)
JP2007505879A (ja) 既知の抗高脂血症剤の多形体
CN107531634A (zh) 作为wnt信号通路抑制剂的3‑氨基甲酰基苯基‑4‑甲酰胺和间苯二甲酰胺衍生物
JP2013541589A5 (enExample)
AU2022283883B2 (en) Novel oxazole derivative and pharmaceutical composition containing same for prevention or treatment of allergic disease
JP2015521994A5 (enExample)
CN105745193B (zh) 抗真菌氧代二氢吡啶碳酰肼衍生物
ES2965478T3 (es) Protodescarboxilación catalizada por metales de transición de derivados del ácido alfa-halo-acrílico